Additionally, positive findings from trials like ADRIATIC (NCT03703297) and IMforte (NCT05091567) are further shaping ...

Q3 2024 Earnings Call Transcript November 6, 2024 Lantheus Holdings, Inc. beats earnings expectations. Reported EPS is $1.79, ...

Welcome to the Lantheus Third Quarter 2024 Conference Call. All lines have been placed on mute. This call is being recorded and a replay will be available in the Investors section of the company's ...

esmo group (esmo), a leading global full-service systems integrator, developer, and supplier of innovative and advanced automation solutions, is proud to announce the launch of its latest product—the ...

The data was still under wraps at that time, but has just been revealed in the ESMO congress abstract drop – a 3.2 month improvement over control, compared to 1.6 months at ASCO. Taken in ...

Now, new data from the POD1UM-303 study reported at ESMO suggests the company could resurrect the SCAC indication and move Zynyz into the first-line setting to boot. Given in combination with ...

The government's new guidelines are a direct response to this judicial directive. The order mandates annual first-aid training for all school staff, equipping them with essential life-saving ...

Doctors use different systems for staging bowel cancer. The most common system for bowel cancer is TNM staging. The Dukes' staging system is not really used anymore. But you might hear your doctor ...

CMS released its 2025 Physician Fee Schedule Nov. 1, finalizing a conversion factor of $32.35, down from $33.29 in 2024. The American Society of Clinical Oncology analyzed how the updates will ...

Nov. 7, 2024 — Researchers have identified a possible way to make glioblastoma cells vulnerable to different types of immunotherapy. The strategy, which they demonstrated in cells in the lab ...

Experts from Duke Cancer Institute discuss the creation of individualized management plans to transition patients from oncologist to primary care physician. Beyond Cancer: A Multidisciplinary ...

Led by forensic pathologist Andreas G. Nerlich of Ludwig-Maximilians-University in Munich, a team of international experts propose that Michelangelo's fresco "The Flood" in the Sistine Chapel ...